Trials / Completed
CompletedNCT00241072
Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
A Single Center, Open Label, Single Arm Trial To Evaluate The Effect Of Twenty Four Weeks Of Treatment With 80 Mg To 320 Mg Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance (Igt)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
THE PURPOSE OF THIS STUDY IS TO DETERMINE IF 24 WEEKS OF TREATMENT WITH VALSARTAN (80 MG - 320 MG) IMPROVES INSULIN SENSITIVITY IN SUBJECTS WITH HIGHER THAN NORMAL GLUCOSE LEVELS USING A TEST CALLED THE EUGLYCEMIC CLAMP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valsartan | 24 WEEKS OF TREATMENT WITH VALSARTAN (80 MG - 320 MG) |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2005-07-01
- Completion
- 2005-07-01
- First posted
- 2005-10-18
- Last updated
- 2012-05-04
Source: ClinicalTrials.gov record NCT00241072. Inclusion in this directory is not an endorsement.